Nano-formulation of rifampicin with enhanced bioavailability: Development, characterization and in-vivo safety-Reference-Cited by-同舟云学术

Nano-formulation of rifampicin with enhanced bioavailability: Development, characterization and in-vivo safety

Published:2015-05 Issue:1-2 Volume:485 Page:138-151
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Singh Harinder,Jindal Sahil,Singh Mandeep,Sharma Gaurav,Kaur Indu Pal^ORCID

Funder

Department of Biotechnology, Government of India

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference55 articles.

1. Alginate nanoparticles as antituberculosis drug carriers: formulation, development, pharmacokinetics and therapeutic potential;Ahmad;Indian J. Chest Dis. Allied Sci.,2006

2. Pharmacological studies of rifampicin;Aratani;Jpn. J. Antibiot.,1970

3. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin;Backman;Eur. J. Clin. Pharmacol.,1998

4. A method to prepare solid lipid nanoparticles with improved entrapment efficiency of hydrophilic drugs;Bhandari;Curr. Nanosci.,2013

5. Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles;Bhandari;Int. J. Pharm.,2013

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mannose-Decorated Solid-Lipid Nanoparticles for Alveolar Macrophage Targeted Delivery of Rifampicin;Pharmaceutics;2024-03-20

2. Enhancing lymphatic uptake of Darunavir Ethanolate through TPGS-enriched lipid nanocarriers for oral delivery;Particulate Science and Technology;2024-03-03

3. Nanomedicine in infectious disease challenges and regulatory concerns;Nanostructured Drug Delivery Systems in Infectious Disease Treatment;2024

4. Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments;Clinical Microbiology Reviews;2023-12-20

5. Advanced drug delivery and therapeutic strategies for tuberculosis treatment;Journal of Nanobiotechnology;2023-11-09